ImmunoIVD is a specialized and research-intensive Swedish company that was established in 2015 by a group of researchers. Their primary goal was to develop a highly sensitive SCID assay for routine newborn screening laboratories. They found success with their SPOT-it™ kits, which were chosen for the national screening programs in the Netherlands and Sweden after successful pilot studies in both countries.

Since then, ImmunoIVD has become a proud provider of their products to several laboratories across various European countries. Their focus is on developing fast and effective assays for newborn screening, specifically targeting primary immunodeficiencies and other rare diseases. By facilitating early detection and prompt treatment, they strive to contribute to better outcomes for children affected by these conditions.

With a commitment to quality and innovation, ImmunoIVD continues to lead the way in the field of diagnostic testing. Their dedication to improving the lives of individuals with primary immunodeficiencies sets them apart as a trusted and reliable partner in the medical community. Contact ImmunoIVD at support@immunoivd.

com or info@immunoivd. com or by phone at +46 840 88 98 00. Learn more about their work by visiting their LinkedIn page